HFD, n = 8
Rescue experiments using the Wnt agonist BML-284 reverted the phenotypic change in both EMT markers, restoring the cancer phenotype and confirming the signalling pathway-specific mechanism of caudatin action (Figure 2)
Morris JK, Vidoni ED, Perea RD, Rada R, Johnson DK, Lyons K, et al
We can send multiple nurses at once to handle larger groups, or one nurse can do the group sequentially
A Certificate of Analysis is included with every order and is also available for download from the product page
414 Emerging drugs and uricosuric compounds Given the advancements in drug delivery systems and a deeper understanding of renal mechanisms and urate transporters, numerous novel therapeutic agents for managing hyperuricemia are currently in various stages of clinical development